New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

MD Anderson says the collaborative, set to begin in 2026, will combine the two institutions’ patient populations to “increase pediatric cancer clinical trials.” ...

LIFE-SAVING WORK: A Houston doctor's work transformed leukemia treatment. Next up: Helping patients avoid chemotherapy. In its own statement, MD Anderson said it's monitoring the developments ...

While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to ...

Texas Medical Center protest was part of a nationwide "Stand Up for Science" day of protest following the National Institutes ...

MD Anderson Cancer Center researchers reveal that more women are being diagnosed with cervical cancer. However, doctors ...

HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According ...

Beyond documentation, healthcare technology company Baxter announced a wearable badge for nurses on Tuesday called Voalte ...

MD Anderson provides cancer care at several convenient locations throughout the Greater Houston Area and collaborates with community hospitals and health systems nationwide through MD Anderson ...

Houston-based University of Texas MD Anderson Cancer Center will establish a nursing leadership academy as part of the center's Meyers Institute for Oncology Nursing with a $9 million gift from the ...